JOINT FILING AGREEMENTJoint Filing Agreement • March 24th, 2023 • Aesther Healthcare Sponsor, LLC • Pharmaceutical preparations
Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”), the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder (including any amendment, restatement, supplement, and/or exhibit thereto) with respect to securities of Ocean Biomedical, Inc., a Delaware corporation, and further agree, in accordance with Rule 13d-1(k) under the Exchange Act, to the filing, furnishing, and/or incorporation by reference of this Joint Filing Agreement (this “Agreement”) as an exhibit thereto. The undersigned acknowledge and agree that each party to this Agreement is responsible for the timely filing of such filings and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein; but none of them is responsible for the completeness
LOAN MODIFICATION AGREEMENTLoan Modification Agreement • March 24th, 2023 • Aesther Healthcare Sponsor, LLC • Pharmaceutical preparations • Delaware
THIS LOAN MODIFICATION AGREEMENT (this “Agreement”), made this 22nd day of March, 2023, by and among NPIC Limited (the “Lender”), Ocean Biomedical, Inc. f/k/a Aesther Healthcare Acquisition Corp. (the “Company”) and Aesther Healthcare Sponsor, LLC (the “Sponsor” or “Borrower”). Lender, Company and Sponsor are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
